165 results
Search Results
2. Fanconi Syndrome in Patients With Human Immunodeficiency Virus Treated With Tenofovir-Based Antiretroviral Therapy: A Systematic Literature Review.
- Author
-
Joshi, Mrinmayee, Clark, Brendan, and Lee, Todd A.
- Subjects
FANCONI syndrome ,HIV ,ANTIRETROVIRAL agents ,CLINICAL trials ,NEPHROTOXICOLOGY - Abstract
Objective: Several cases of Fanconi syndrome (FS), a severe form of nephrotoxicity, have been reported in patients with HIV on tenofovir-containing antiretroviral therapy. A systematic review of the published literature on tenofovir-related FS in patients with HIV was conducted. Data Sources: PubMed and Embase were queried to identify articles in English published between January 2005 and June 2023, reporting tenofovir-related FS in adults with HIV. Preclinical studies, conference/poster abstracts, commentaries and responses, and review papers were excluded. Study Selection and Data Extraction: Of the 256 articles screened, 57 met the inclusion criteria. These comprised 37 case reports, 11 case series, 1 cross-sectional study, 1 case-control study, 4 cohort studies, 1 single-arm open-label clinical trial, 1 sub-analysis of clinical trials, and 1 pooled analysis of clinical trials. Data Synthesis: Among 56 cases on which information was abstracted, median age at FS diagnosis was 50 years, 51.8% were men, and duration of tenofovir use ranged from 6 weeks to 11 years. Ritonavir was co-prescribed in almost half the cases. In observational and interventional studies, incidence of FS was low. Many studies reported resolution of FS symptoms after tenofovir discontinuation. All FS occurrences were identified in those on tenofovir disoproxil fumarate (TDF), except for one patient on tenofovir alafenamide (TAF). Relevance to Patient Care and Clinical Practice: Continuous monitoring of signs and symptoms of renal and bone toxicity is essential for patients with HIV on tenofovir-containing therapy. Conclusions: Occurrence of FS is low in patients with HIV treated with tenofovir-based regimens. Concomitant use of ritonavir may increase risk of FS. TAF may be a safer alternative than TDF in terms of nephrotoxicity. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. The Relational Virtual Nursing Practice Model: A Web-Based Nursing Intervention.
- Author
-
Rouleau, Geneviève, Richard, Lauralie, Côté, José, and Ramirez-Garcia, Maria Pilar
- Subjects
HIV-positive persons ,EVALUATION of human services programs ,NURSING ,INTERNET ,VIRTUAL reality ,ANTIRETROVIRAL agents ,MEDICAL care ,NURSING theory ,SELF-efficacy ,NURSING practice ,QUALITATIVE research ,HUMAN services programs ,NURSE-patient relationships ,DESCRIPTIVE statistics ,RESEARCH funding ,NURSING interventions ,HEALTH promotion - Abstract
This discussion paper aimed to reflect on the development of relational connections in the context of a web-based, tailored, asynchronous nursing intervention (VIH-TAVIE
TM ) aimed at empowering people living with HIV in taking their antiretroviral treatment. Our reflection culminates in the Relational Virtual Nursing Practice Model. This paper builds on nurse-researchers and people living with HIV's experiences, nursing theories, and cross-disciplinary work on relational engagement. The model shows the disciplinary principles underpinning VIH-TAVIETM , engagement processes used to create humanistic and supportive relational environment and people's relational experiences and it contributes to the development of conceptual nursing knowledge on how generating meaningful relational nursing care in virtual environments. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
4. Couple-Based Behavioral HIV Interventions by the Social Intervention Group: Progress, Gaps, and Future Directions.
- Author
-
El-Bassel, Nabila, Hunt, Tim, Goddard-Eckrich, Dawn A., Chang, Mingway, McCrimmon, Tara R., Mukherjee, Trena, Remien, Robert H., Terlikbayeva, Assel, Primbetova, Sholpan, Davis, Alissa, Jiwatram-Negrón, Tina, Benjamin, Shoshana N., Witte, Susan S., Wu, Elwin, and Gilbert, Louisa
- Subjects
SUBSTANCE abuse prevention ,HIV prevention ,HIV infections ,NEEDLE exchange programs ,RISK-taking behavior ,HUMAN sexuality ,ANTIRETROVIRAL agents ,COUPLES therapy ,BEHAVIOR therapy ,MEDICAL screening ,DRUGS ,SEX customs ,PATIENT compliance ,SOCIAL case work - Abstract
Purpose: This paper reports a review of couple-based behavioral HIV interventions conducted by the Social Intervention Group (SIG); and addresses gaps, future directions, and implications for couple-based HIV interventions. Method: We performed a literature review for SIG research on intervention and prevention studies involving couples/partners. Results: We identified nine couple-based interventions. Outcomes included reduced sexual and substance use-related risk behaviors and improved use of anti-retroviral treatment. We conducted these studies in diverse venues, including needle/syringe exchange programs, primary care clinics, and criminal justice settings. Conclusions: The findings of this review provide strong evidence for the efficacy of couple-based HIV interventions in reducing sexual HIV risks and linkage to HIV and substance-use treatment. SIG has advanced couple-based HIV intervention research science by improving study design, intervention core components, conceptual models, and implementation strategies; which have informed scientific directions and transformed couple-based HIV prevention research. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. Implementation of a Dyad-Based Intervention to Improve Antiretroviral Therapy Adherence Among HIV-Positive People Who Inject Drugs in Kazakhstan: A Randomized Trial.
- Author
-
Davis, Alissa, Mergenova, Gaukhar, Landers, Sara E., Sun, Yihang, Rozental, Elena, Gulyaev, Valera, Gulyaev, Pavel, Nurkatova, Mira, Terlikbayeva, Assel, Primbetova, Sholpan, Altice, Frederick L., and Remien, Robert H.
- Subjects
HIV infections ,FRIENDSHIP ,PILOT projects ,INTRAVENOUS drug abusers ,SOCIAL support ,ANTIRETROVIRAL agents ,INTERVIEWING ,MEDICAL care ,HUMAN services programs ,RANDOMIZED controlled trials ,DRUGS ,PSYCHOSOCIAL factors ,INTERPERSONAL relations ,RESEARCH funding ,QUALITY assurance ,DESCRIPTIVE statistics ,PATIENT compliance ,PATIENT care ,STATISTICAL sampling ,SEXUAL partners ,FAMILY relations ,INTEGRATED health care delivery ,DATA analysis software ,PSYCHOLOGY of HIV-positive persons - Abstract
Purpose: HIV-positive people who inject drugs (PWID) in Kazakhstan face many challenges to antiretroviral therapy (ART) adherence. Interventions that leverage social support from an intimate partner, family member, or friend may be effective in improving ART adherence among this population. The purpose of this paper is to describe the implementation process of a dyad-based intervention among HIV-positive PWID and their treatment support partners. Method: Sixty-six HIV-positive PWID and 66 of their treatment support partners will be enrolled in this pilot randomized controlled trial in Almaty, Kazakhstan, and randomized as dyads to receive an adapted version of the SMART Couples intervention or standard of care. Results: Several implementation strategies were used to facilitate intervention delivery, including remote delivery, training of staff, supervision, technical assistance, quality assurance, and collection of assessments through diverse sources. Discussion: This trial responds to a need for dyad-based ART adherence interventions adapted specifically for HIV-positive PWID. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. Bayesian semiparametric growth models for measurement error and missing data in CD4/CD8 ratio: Application to AIDS Study.
- Author
-
Dagne, Getachew A
- Subjects
ERRORS-in-variables models ,MEASUREMENT errors ,AIDS ,MISSING data (Statistics) ,GROWTH curves (Statistics) ,ANTIRETROVIRAL agents ,ANTI-HIV agents ,DISEASE progression ,VIRAL load ,STATISTICAL models ,PROBABILITY theory - Abstract
In clinical research and practice, there is often an interest in assessing the effect of time varying predictors, such as CD4/CD8 ratio, on immune recovery following antiretroviral therapy. Such predictors are measured with errors, and ignoring those measurement errors during data analysis may lead to biased results. Though parametric methods have been used for reducing biases, they usually depend on untestable assumptions. To relax those assumptions, this paper presents semiparametric mixed-effect models which deal with predictors having measurement errors and missing values. We develop a fully Bayesian approach for fitting these models and discriminating between patients who are potentially progressors or nonprogressors to severe disease condition (AIDS). The proposed methods are demonstrated using real data from an AIDS clinical study. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
7. Is fear of disease progression associated with antiretroviral therapy adherence in persons with HIV/AIDS?
- Author
-
Yeom, Chan-Woo, Ha, Hyeju, Hahm, Bong-Jin, Hee Lee, Sun, Joong Kim, Nam, and Shim, Eun-Jung
- Subjects
FEAR ,PATIENT compliance ,SELF-evaluation ,ANTIRETROVIRAL agents ,ATTITUDES toward illness ,RESEARCH funding ,ANXIETY ,DESCRIPTIVE statistics ,PSYCHOLOGY of HIV-positive persons ,DRUGS ,SOCIAL support ,FACTOR analysis ,DISEASE progression ,MENTAL depression - Abstract
We examined the mediating role of depression and anxiety on the relationship between fear of disease progression (FoP) and antiretroviral therapy (ART) adherence and the moderating role of social support in the FoP-depression/anxiety-ART adherence relationship in persons with HIV/AIDS (PWHA). 202 PWHA completed self-report measures. Simple mediation and moderated mediation analyses were performed. FoP was directly and negatively associated with ART adherence, and the mediating role of depression in this relationship was significant. Indirect effect of FoP mediated by anxiety on ART adherence was not significant. The moderating effect of social support was significant in the FoP-depression pathway, while the indirect effect of FoP on ART adherence mediated by depression was greatest at a higher level of social support and lower level of FoP. The results suggest the relevance of high FoP and depression-mediated FoP in ART adherence and social support may attenuate the negative impact of FoP. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Cost of antiretroviral treatment for HIV patients in two centres of North India.
- Author
-
Sharma, Atul, Prinja, Shankar, Sharma, Aman, Gupta, Aditi, and Arora, Sunil K
- Subjects
HIV-positive persons ,THERAPEUTICS ,ANTIRETROVIRAL agents ,DRUG prices ,MEDICAL care costs ,HIV infection epidemiology ,MEDICAL care cost statistics ,HIV infections ,COST analysis ,HIGHLY active antiretroviral therapy ,ANTI-HIV agents ,AIDS serodiagnosis - Abstract
There is paucity of evidence on cost of antiretroviral therapy (ART) delivered through the public sector in India. Moreover, the Government of India is considering changing the criteria for introduction of ART to HIV patients, which is likely to have significant economic implications. In this paper, we assess the health system cost of ART services at two levels of health care delivery. Bottom-up costing was used to collect data on capital and recurrent resources consumed over a period of one year (April 2014–March 2015). Capital costs were annualized and shared costs apportioned to calculate annual and unit costs of providing ART care. Sensitivity analysis was undertaken to measure the extent of uncertainty in input prices. The annual per capita cost of ART therapy was INR 48,975 (USD738) in the Centre of Excellence (COE) and INR 24,954 (USD376) in the ART centre. Drugs contributed around 70% and 65% of total annual cost, followed by human resource (19% each) and capital cost (7%; 12%) in COE and ART centres, respectively. These provide a comprehensive assessment of the cost of ART care in India. The study estimates could be used for planning of services, as well as undertaking further cost-effectiveness studies. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
9. A hierarchical modeling approach for assessing the safety of exposure to complex antiretroviral drug regimens during pregnancy.
- Author
-
Correia, Katharine and Williams, Paige L.
- Subjects
ANTIRETROVIRAL agents ,MEDICATION safety ,HIV-positive women ,PREGNANT women ,MEDICAL screening - Abstract
Combination antiretroviral regimens have achieved tremendous success in reducing perinatal HIV transmission, and have become standard of care in pregnant women with HIV. However, the large variety of combination antiretroviral regimens utilized in practice raises the question of whether some of these highly potent drugs pose other risks to the pregnancy or infant. While HIV-infected pregnant women are almost always exposed to multiple antiretrovirals concurrently, standard safety screening strategies typically consider each individual antiretroviral separately, which fails to account for potential confounding due to simultaneous exposure to other antiretrovirals. In this paper, we evaluate a hierarchical modeling approach which groups antiretrovirals by drug class to screen for the safety of antiretrovirals taken during pregnancy, while still providing individual antiretroviral drug effect estimates. In simulation studies, we observed that the hierarchical approach may be advantageous as compared to considering each antiretroviral drug separately or simultaneously evaluating all antiretrovirals in a fixed effect model, particularly when there is prior evidence suggesting drugs from the same class behave similarly on the outcome. The characteristics of the hierarchical approach are illustrated in an application evaluating risk of preterm birth using a study including over 2000 pregnancies representing over 100 antiretroviral combinations, each involving up to three drug classes. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
10. Prevalence of oral candidiasis in HIV/AIDS children in highly active antiretroviral therapy era. A literature analysis.
- Author
-
Gaitán-Cepeda, Luis Alberto, Sánchez-Vargas, Octavio, and Castillo, Nydia
- Subjects
THRUSH (Mouth disease) ,AIDS in children ,HIV ,DISEASE prevalence ,ANTIRETROVIRAL agents - Abstract
Highly active antiretroviral therapy has decreased the morbidity and mortality related to HIV infection, including oral opportunistic infections. This paper offers an analysis of the scientific literature on the epidemiological aspects of oral candidiasis in HIV-positive children in the combination antiretroviral therapy era. An electronic databases search was made covering the highly active antiretroviral therapy era (1998 onwards). The terms used were oral lesions, oral candidiasis and their combination with highly active antiretroviral therapy and HIV/AIDS children. The following data were collected from each paper: year and country in which the investigation was conducted, antiretroviral treatment, oral candidiasis prevalence and diagnostic parameters (clinical or microbiological). Prevalence of oral candidiasis varied from 2.9% in American HIV-positive children undergoing highly active antiretroviral therapy to 88% in Chilean HIV-positive children without antiretroviral therapy. With respect to geographical location and antiretroviral treatment, higher oral candidiasis prevalence in HIV-positive children on combination antiretroviral therapy/antiretroviral therapy was reported in African children (79.1%) followed by 45.9% reported in Hindu children. In HIV-positive Chilean children on no antiretroviral therapy, high oral candidiasis prevalence was reported (88%) followed by Nigerian children (80%). Oral candidiasis is still frequent in HIV-positive children in the highly active antiretroviral therapy era irrespective of geographical location, race and use of antiretroviral therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
11. Bayesian two-part bent-cable Tobit models with skew distributions: Application to AIDS studies.
- Author
-
Dagne, Getachew A.
- Subjects
TOBITS ,DRUG resistance ,SKEWNESS (Probability theory) ,DISTRIBUTION (Probability theory) ,ANTIRETROVIRAL agents - Abstract
This paper presents a new development of a bent-cable two-part Tobit model to identify both phasic patterns and mixture of advancing (to AIDS) and non-advancing patients of HIV. In identification of such phasic patterns, estimation of a transition period for the development of drug resistance to antiretroviral (ARV) drug or therapy is carried out using longitudinal data that have a gradual change from a declining phase to an increasing phase. In addition to phasic changes, there are also problems of skewness and left-censoring in the response variable because of a lower limit of detection. A relatively large percentage of data below limit of detection are recorded more than expected under an assumed skew-distribution. To properly accommodate these features, we present an extension of the random effects bent-cable Tobit model that incorporates a mixture of true undetectable observations and those values from a skew-normal distribution for a response with left-censoring, skewness and phasic patterns. The proposed methods are illustrated using real data from an AIDS clinical study. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
12. Detecting and accounting for violations of the constancy assumption in non-inferiority clinical trials.
- Author
-
Koopmeiners, Joseph S. and Hobbs, Brian P.
- Subjects
PLACEBOS ,MEDICAL research ,BAYESIAN analysis ,RALTEGRAVIR ,ANTIRETROVIRAL agents ,HIV infections ,THERAPEUTICS - Abstract
Randomized, placebo-controlled clinical trials are the gold standard for evaluating a novel therapeutic agent. In some instances, it may not be considered ethical or desirable to complete a placebo-controlled clinical trial and, instead, the placebo is replaced by an active comparator with the objective of showing either superiority or non-inferiority to the active comparator. In a non-inferiority trial, the experimental treatment is considered non-inferior if it retains a pre-specified proportion of the effect of the active comparator as represented by the non-inferiority margin. A key assumption required for valid inference in the non-inferiority setting is the constancy assumption, which requires that the effect of the active comparator in the non-inferiority trial is consistent with the effect that was observed in previous trials. It has been shown that violations of the constancy assumption can result in a dramatic increase in the rate of incorrectly concluding non-inferiority in the presence of ineffective or even harmful treatment. In this paper, we illustrate how Bayesian hierarchical modeling can be used to facilitate multi-source smoothing of the data from the current trial with the data from historical studies, enabling direct probabilistic evaluation of the constancy assumption. We then show how this result can be used to adapt the non-inferiority margin when the constancy assumption is violated and present simulation results illustrating that our method controls the type-I error rate when the constancy assumption is violated, while retaining the power of the standard approach when the constancy assumption holds. We illustrate our adaptive procedure using a non-inferiority trial of raltegravir, an antiretroviral drug for the treatment of HIV. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
13. Determination of the Antiretroviral Drug Acyclovir in Diluted Alkaline Electrolyte by Adsorptive Stripping Voltammetry at the Mercury Film Electrode.
- Author
-
Aguiar Castro, Arnaldo, Perez Cordoves, Ana Isa, and Mardini Farias, Percio Augusto
- Subjects
ANTIRETROVIRAL agents ,ACYCLOVIR ,ELECTROLYTES ,VOLTAMMETRY ,ELECTRODES ,THIN films ,LAMIVUDINE ,ADENOSINE triphosphatase - Abstract
This paper describes a stripping method for the determination of acyclovir at the submicromolar concentration level. This method is based on controlled adsorptive accumulation of acyclovir at thin-film mercury electrode, followed by a linear cyclic scan voltammetry measurement of the surface species. Optimal experimental conditions include a NaOH solution of 2.0 × 10
-3 mol L-1 (supporting electrolyte), an accumulation potential of -0.40 V, and a scan rate of 100 mV s-1 . The response of acyclovir is linear over the concentration range 0.02 to 0.12 ppm. For an accumulation time of 4 minutes, the detection limit was found to be 0.42 ppb (1.0 × 10-9 mol L-1 ). More convenient methods to measure the acyclovir in presence of the didanosine, efavirenz, nevirapine, nelfinavir, lamivudine, and zidovudine were also investigated. The utility of this method is demonstrated by the presence of acyclovir together with Adenosine triphosphate (ATP) or DNA. [ABSTRACT FROM AUTHOR]- Published
- 2013
- Full Text
- View/download PDF
14. The utility of population-based surveys to describe the continuum of HIV services for key and general populations.
- Author
-
Hladik, Wolfgang, Benech, Irene, Bateganya, Moses, and Hakim, Avi J.
- Subjects
HIV infections ,THERAPEUTICS ,ANTIRETROVIRAL agents ,HIV prevention ,PATIENT monitoring ,VIRAL load ,CONTINUUM of care ,T cells ,ANTI-HIV agents ,CD4 lymphocyte count - Abstract
Monitoring the cascade or continuum of HIV services - ranging from outreach services to anti-retroviral treatment - has become increasingly important as the focus in prevention moves toward biomedical interventions, in particular, 'Treatment as Prevention.' The HIV continuum typically utilises clinic-based care and treatment monitoring data and helps identify gaps and inform programme improvements. This paper discusses the merits of a population-based survey-informed continuum of services. Surveys provide individual-level, population-based data by sampling persons both in and outside the continuum, which facilitate the estimation of population fractions, such as the proportion of people living with HIV in care, as well as the examination of determinants for being in or outside the continuum. Survey-informed cascades of services may especially benefit key populations at increased risk for HIV infection for who social marginalisation, criminalisation, and stigma result in barriers to access and retention in services, a low social visibility, mobility, and outreach-based services can compromise clinic-based monitoring. Adding CD4+ T-cell count and viral load measurements to such surveys may provide population-level information on viral load suppression, stage of disease, treatment needs, and population-level transmission potential. While routine clinic-based reporting will remain the mainstay of monitoring, a survey-informed service cascade can address some of its limitations and offer additional insights. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
15. State of the (positive) nation: findings from the fourth national Australian HIV futures survey.
- Author
-
Grierson, J. W., Pitts, M. K., and Thorpe, R. D.
- Subjects
AIDS patients ,HIV-positive persons ,HIV infections ,HEALTH ,WELL-being ,QUALITY of life ,ANTIRETROVIRAL agents ,VIRAL load - Abstract
This paper characterises the health and wellbeing of people living with HIV/AIDS (PLWHA) in Australia. The HIV Futures 4 Survey is a self-complete anonymous questionnaire distributed through multiple sites. Data were collected on health, clinical and social variables. There were 1059 responses, approximately 8% of the estimated HIV-positive population. Respondents were aged between 18 and 92 years and 77% were homosexual men. In total, 60% reported a viral load of <500 copies/mL and 83% a CD4 count of over 250 cells/μL. A total of 44% reported another major health condition and 35% a mental health condition. A total of 71% were using antiretroviral therapy. More than half of the respondents had stopped working because of HIV and 25% were living in poverty. In conclusion, adequate planning for the future of our response to HIV/AIDS relies in no small part on our access to detailed information about how the epidemic affects those with the virus. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
16. AIDS-defining illness diagnosed within 90 days after starting highly active antiretroviral therapy among patients from the TREAT Asia HIV Observational Database.
- Author
-
Zhou, J., Paton, N. I., and Ditangco, R.
- Subjects
AIDS ,HIV ,HIV-positive persons ,ANTIRETROVIRAL agents ,THERAPEUTICS - Abstract
Using data from TREAT Asia HIV Observational Database (TAHOD), this paper aims to assess the rate of, and factors associated with the diagnosis of new AIDS-defining illness (ADI) within 90 days after antiretroviral treatment. Patients starting three or more antiretroviral combinations and having subsequent follow-up were included. New ADI cases were checked for evidence of immune reconstitution syndrome (IRS). Among the 1185 patients included, 75 (6.3%) were diagnosed with a new ADI within 90 days, giving a rate of 26.8/100 person-years, compared with a further 3.6% cumulative incidence of new ADI between 90 days to one year (4.2/100 person-years). Of the 75 patients, 21 were judged as definitive or presumptive IRS, giving a rate of 7.3/100 person-years. Patients with new ADI generally had lower CD4 counts before treatment started (median, 43 cells/μL). Lower CD4 count, lower body mass index and starting treatment in the same year as the first HIV-positive test done were associated with developing a new ADI. The higher rate of new ADI within 90 days may be partly explained by IRS occurring shortly after treatment. Although it is difficult to identify IRS from observational data, it appears that in TAHOD setting IRS was relatively uncommon. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
17. Efficacy of interventions in improving adherence to antiretroviral therapy.
- Author
-
Côté, José K. and Godin, Gaston
- Subjects
ANTIRETROVIRAL agents ,CLINICAL medicine ,MEDICAL care ,HEALTH - Abstract
The aim of this paper is to perform a critical review of the effectiveness of interventions for the purpose of enhancing adherence to antiretroviral therapy. The overall evaluation indicates that research is in its early stages. Although pilot studies provide support for the feasibility of their protocols, and preliminary results also suggest their capacity to improve adherence, only three major trials have reported significant improvement in adherence. The issues that will have to be addressed by future studies include: (a) the need for a theoretical and empirical understanding of the phenomena; (b) adoption of a format that fits the attributes of the population; (c) the use of multiple strategies involving key providers; (d) a concise and precise schedule governing the frequency and intensity of the intervention; (e) a careful selection of direct outcome; and (f) appropriate time measurement. In sum, greater efforts to design and evaluate interventions are needed to lead to an increase in adherence and improvement in treatment effectiveness. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
18. Antiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy.
- Author
-
Reid, S. E., Reid, C. A., and Vermund, S. H.
- Subjects
HIV ,ANTIRETROVIRAL agents ,HIV-positive persons ,TUBERCULOSIS ,HANSEN'S disease - Abstract
Declining drug costs and increases in international donor interest are leading to greater availability of antiretroviral treatment programmes for persons living with the human immunodeficiency virus in parts of sub-Saharan Africa. Ensuring adequate adherence to antiretroviral drug therapy is one of the principal challenges facing successful implementation in Africa, where 70% of the world's infected persons live. Tuberculosis and leprosy are two diseases of global importance whose control programmes can provide important lessons for developing antiretroviral drug adherence strategies. This paper examines various approaches used in tuberculosis and leprosy control which could help enhance adherence to antiretroviral therapy in resource-limited settings. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
19. Predictors of Opportunistic Infections among HIV-infected Patients on Antiretroviral Therapy: A Cross-Sectional Study.
- Author
-
Hailu Gebru, Tsegu, Hagos Mekonen, Haftea, Gemechu, Kbrom, Gebremedhin, Haftom Tesfay, Tadesse, Beyene, and Tesfamichael, Yohannes Ashebir
- Subjects
OPPORTUNISTIC infections ,HIV-positive persons ,CONFIDENCE intervals ,CROSS-sectional method ,MULTIVARIATE analysis ,FUNCTIONAL status ,DISEASES ,IMMUNOSUPPRESSION ,INTERVIEWING ,ANTIRETROVIRAL agents ,QUESTIONNAIRES ,DESCRIPTIVE statistics ,PREDICTION models ,LOGISTIC regression analysis ,DATA analysis software ,COVID-19 pandemic ,AIDS - Abstract
Opportunistic infections (OIs) are diseases that cause infections in people whose immune systems are compromised. The purpose of this study was to assess the prevalence of OIs and associated factors among HIV-infected patients. Institutional-based cross-sectional study was done in Eastern Zone, Tigray, Ethiopia. A structured questionnaire was used to collect the data from 394 study participants through an interview method. The required sample size was determined using a single population proportion formula. Participants were selected using a systematic random sampling method. Data was entered and analyzed using SPSS version 22. Multivariable logistic regression analysis was used to find factors at p <.05. The prevalence of OIs was found to be 52% (95% CI [47.5, 57.1]). Occupation, CD4+ count, adherence to antiretroviral therapy (ART), and functional status were independently associated with OIs. Intervention measures such as improving adherence to ART should be strengthened to further reduce the burden of OIs. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
20. Linking Paradigms and Methodologies in a Qualitative Case Study Focused On Exploring the Operation of Power in Human Actions During the Design of a New Occupational Therapy Intervention.
- Author
-
Gretschel, Pam, Ramugondo, Elelwani L., and Galvaan, Roshan
- Subjects
OCCUPATIONAL therapy ,ANTIRETROVIRAL agents ,QUALITATIVE research ,OCCUPATIONAL therapists ,RESEARCH methodology - Abstract
A research paradigm represents how a researcher views the nature of reality and guides how they engage in research to generate knowledge from that reality. Power is a construct that impacts on the individual actions of the researcher and the participants, and their interactions with each other, across a range of perspectives of reality. Qualitative researchers select different paradigmatic stances to represent how they consider and work with the influences of power on these human relations. This influences their decisions about which research design and methodology they select. Drawing on my doctoral study, which explored the process by which a group of occupational therapists designed an intervention for caregivers of children on anti-retroviral treatment living in low-income conditions in South Africa, I describe my process of selecting a poststructuralist paradigm, an instrumental case study design, and a co-operative inquiry methodology to illuminate the operation of power in the research process. An overview of the potential offerings and limitations of different paradigms, research designs and methods, as applied to this research example, are presented to support my assertions. In conclusion, I argue for the more consistent consideration and description of the interplay between paradigms, research design and methodology, to ensure the selection of the best suited combination to explore and describe the influences of power in the research process. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
21. Adverse Impact of Intimate Partner Violence Against HIV-Positive Women During Pregnancy and Post-Partum: Results From a Meta-Analysis of Observational Studies.
- Author
-
Lin, Dan, Zhang, Chunyang, and Shi, Huijing
- Subjects
MENTAL depression risk factors ,HIV-positive persons ,ONLINE information services ,MEDICAL databases ,META-analysis ,MEDICAL information storage & retrieval systems ,SYSTEMATIC reviews ,PREGNANT women ,ANTIRETROVIRAL agents ,INTIMATE partner violence ,SELF-disclosure ,PRE-exposure prophylaxis ,PUERPERIUM ,DRUGS ,MEDLINE ,PATIENT compliance - Abstract
Objectives : Intimate partner violence (IPV) against pregnant or human immunodeficiency virus (HIV)-positive women have been previously studied. However, data on the impact of IPV on HIV-positive pregnant women have not been systematically synthesized. We performed a meta-analysis to explore this issue and provide evidence regarding IPV prevention and HIV infection control. Method : The PubMed, Web of Science, Cochrane Library, and Embase databases were systematically searched. Studies that quantitatively assessed the association between IPV and its adverse impact on HIV-positive women during pregnancy and post-partum were eligible for inclusion. Pooled odds ratios (ORs) were calculated. Findings: Eight studies were identified to meet our eligibility criteria. The adverse impacts of IPV against HIV-positive pregnant women mainly included nonadherence to maternal antiretroviral treatment during pregnancy, nondisclosure of HIV-positive status to male partners, nonadherence to infant antiretroviral prophylaxis, and antenatal depression. IPV caused a 180% and 145% increase in the odds of antenatal depression and nonadherence to infant antiretroviral prophylaxis, respectively, among HIV-positive women, compared to the odds of their IPV-free counterparts [OR = 2.80, 95% confidence interval (CI): 1.66–4.74; OR = 2.45, 95% CI: 1.40–4.27]. Conclusion : Limited evidence has suggested that IPV against HIV-positive pregnant women caused maternal depression during pregnancy and led to the possible failure of HIV prophylaxis adherence in infants. Interventions to address IPV may ultimately reduce the risk of depression-related adverse birth outcomes and vertical transmission in infants exposed to maternal HIV. Prevention and control against IPV should be developed for HIV-positive pregnant women. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
22. Financing HIV service provision in England: estimated impact of the cost of antiretroviral combination therapy.
- Author
-
Beck, E. J. and Tolley, K.
- Subjects
HIV-positive persons ,MEDICAL care costs ,ANTIRETROVIRAL agents ,HIV ,HOSPITAL charges ,HIV infections ,MEDICAL economics ,ANTI-HIV agents ,COMBINATION drug therapy ,COST analysis ,ECONOMICS - Abstract
The objective of this study was to provide population-based estimates on the cost of HIV service provision in England and the use of dual or triple antiretroviral combination therapy. Contemporary cost estimates of treating HIV-infected individuals by clinical stage of HIV infection (indexed to 1995/96 prices) were linked to the number of diagnosed HIV-infected individuals using statutory medical services in England during 1996. Two cost measures were used: the first one was based on average hospital prices derived from a number of English HIV units. These results were compared with those estimated using standard unit costs obtained through specific costing studies performed at a national HIV referral centre. Overall annual expenditure on HIV service provision was estimated for different treatment scenarios as was expenditure by clinical stage of HIV infection. Using hospital prices, in 1996 the total annual cost estimate for HIV service provision amounted to pound sterling 131 m (range pound sterling 83 m to pound sterling 233 m), or pound sterling 150 m (95% CI pound sterling 126 m to pound sterling 173 m) using standard costs, if all patients with HIV disease were treated with AZT monotherapy. For all eligible patients to be treated with dual therapy, cost estimates amounted to pound sterling 161 m (range pound sterling 126 m to pound sterling 173 m) per year using hospital prices or pound sterling 180 m (95% CI pound sterling 156 m to pound sterling 203 m) when using standard cost estimates, while for triple therapy annual estimated expenditure amounted to pound sterling 204 m per year (range pound sterling 157 m to pound sterling 306 m) when using hospital prices or pound sterling 223 m (95% CI pound sterling 199 m to pound sterling 246 m) using standard costs. Increasingly costs will be more evenly distributed across the 3 stages of HIV infection, with a greater proportion of costs generated by HIV-infected individuals before the onset of AIDS. Using non-standardized hospital prices may systematically underestimate the real cost of service provision. Monitoring prospectively the use, cost and outcome of HIV service provision in a standardized format will provide information on the actual cost impact over the next 2-3 years of combination therapy compared with the scenario-based estimates produced in this paper. [ABSTRACT FROM AUTHOR]
- Published
- 1998
- Full Text
- View/download PDF
23. Governing Oneself Through HIV Diagnosis to Antiretrovirals.
- Author
-
Nkomo, Nkululeko
- Subjects
HIV infections & psychology ,HIV infections ,ANTIRETROVIRAL agents ,INTERVIEWING ,PUBLIC health ,PATIENTS' attitudes ,QUALITATIVE research ,GOVERNMENT programs ,GOVERNMENT policy ,PATIENT compliance ,HEALTH self-care ,HUMAN beings - Abstract
The article focuses on the experience of reinventing oneself post HIV diagnosis when living on antiretrovirals. Six women and men enlisted for antiretrovirals in South African public health facilities were interviewed, and a qualitative analysis was conducted drawing on Foucault's theory of governmentality. For the participants, the prevailing governing rationality of taking personal responsibility for their health is synonymous with self-recovery and restoration of self-determination. From the hopelessness and despair of HIV diagnosis, for all six participants, committing to antiretrovirals enhances their capacity to take back control of their transformation from victim to survivor, and with it, a sense of personal integrity. Yet, an unwavering resolve to use ARVs is not always possible for some of them, is not preferable or is not always desirable, which perhaps signals that for certain people living with HIV, their life-long journey of self-governance with ARVs is likely to be characterized by constant contradictions. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
24. Prevalence and distribution of non-AIDS causes of death among HIV-infected individuals receiving antiretroviral therapy: a systematic review and meta-analysis.
- Author
-
Farahani, Mansour, Mulinder, Holly, Farahani, Alexander, and Marlink, Richard
- Subjects
CAUSES of death ,HIV infections ,THERAPEUTICS ,ANTIRETROVIRAL agents ,CARDIOVASCULAR diseases ,MEDICAL statistics - Abstract
The advent of antiretroviral therapy has significantly improved AIDS-related morbidity and mortality. Yet, among people living with HIV, deaths due to non-AIDS-defining illnesses have been on the rise. The objective of this study was to provide information about the global prevalence and distribution of non-AIDS causes of death in the last ten years among people living with HIV receiving antiretroviral therapy, by income levels of countries. We used broad search terms in Google Scholar, PubMed, and EMBASE to identify all studies that investigated the cause of death among people living with HIV receiving antiretroviral therapy, published after January 1, 2005. References were also identified from review articles and reference lists. Inclusion criteria were English language, the study's end date was after 2005, all patients were HIV-positive, at least two-thirds of the patients were receiving antiretroviral therapy, at least one patient died of non-AIDS causes of death. Titles, abstracts, and articles were reviewed by at least two independent readers. Of 2951 titles identified in our original search, 151 articles were selected for further screening. We identified 19 studies meeting our full criteria, with patients from 55 different nations. Pooled non-AIDS causes of death prevalence estimates in high-income countries were 53.0% (95% confidence interval, 43.6-62.3), in developing countries 34.0% (95% confidence interval, 20.3-49.1), and in sub-Saharan countries 18.5% (95% confidence interval, 13.8-23.7). Statistically significant variation was noted within and between categories. Our findings show that a significant number of people living with HIV across the world die from cardiovascular disease, non-AIDS malignancies, and liver disease. There is a global need for further scrutiny in all regions to improve preventive measures and early detection according to distinct causes of death patterns. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
25. Cervical Cancer Screening Service Utilization and Associated Factors Among Women Living With HIV Receiving Anti-Retroviral Therapy at Adama Hospital Medical College, Ethiopia.
- Author
-
Mohamed, Zubeyda Kedir, Amare, Yirga Wondu, Getahun, Mihiret Shawel, Negussie, Yohannes Mekuria, and Gurara, Abenet Menene
- Subjects
HOSPITALS ,HIV infections ,COMPUTER software ,STATISTICS ,CONFIDENCE intervals ,CROSS-sectional method ,MULTIVARIATE analysis ,EARLY detection of cancer ,ANTIRETROVIRAL agents ,MEDICAL care use ,HEALTH literacy ,SEXUALLY transmitted diseases ,QUESTIONNAIRES ,DESCRIPTIVE statistics ,CERVIX uteri tumors ,DATA analysis software ,LOGISTIC regression analysis ,PUBLIC officers ,STATISTICAL sampling ,WOMEN'S health ,PSYCHOLOGY of HIV-positive persons ,FAMILY history (Medicine) - Abstract
Introduction: Cervical cancer is the second highest cause of cancer-related mortality in the world, and it is one of the top 20 causes of mortality in Ethiopia. Even though cervical cancer is more common among women living with HIV, the utilization of cervical cancer screening services remains low in Ethiopia. Objectives: This study aimed to assess cervical cancer screening service utilization and associated factors among women living with HIV receiving anti-retroviral therapy at Adama Hospital Medical College, Ethiopia. Methods: An institution-based cross-sectional study was conducted among a sample of 304 women living with HIV from 1st–30th June 2022. Data were collected using an interviewer-administered questionnaire. The data were entered into Epi info version 7 and exported to SPSS version 25 for analysis. Bi-variable logistic regression analysis was used to identify candidate variables at p <.25. Finally, multivariable logistic regression analysis was used to identify the independent predictors of cervical cancer screening service utilization at p <.05 with 95% confidence intervals. Results: The magnitude of cervical cancer screening service utilization was 26.9% (95% CI: 22.0, 32.6). Being a government employee (AOR: 8.09, 95% CI: 1.5, 41.19), having a family history of cervical cancer (AOR: 3.4, 95% CI: 1.02, 11.9), being aware of cervical cancer screening (AOR: 3.75, 95% CI: 2.11, 14.7), having a history of sexually transmitted infection (AOR: 3.14, 95% CI: 1.95, 10.2), and heard about cervical cancer (AOR: 2.6, 95% CI: 1.05, 6.41) were associated with cervical cancer screening service utilization. Conclusion: The magnitude of cervical cancer screening service utilization was low. It was associated with occupation status, family history of cervical cancer, awareness about cervical cancer screening, history of STI, and ever heard about cervical cancer. Thus, to maximize utilization, health education programs and other multidisciplinary strategies had to be implemented. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
26. Comparison of time to undetectable HIV viral load in the first 16 weeks after the start of three and four antiretroviral regimens.
- Author
-
Manavi, K. and Scott, G.
- Subjects
HIV ,HIGHLY active antiretroviral therapy ,PATIENTS ,ANTIRETROVIRAL agents ,ANTIVIRAL agents - Abstract
The aim of this paper is to compare the time to a viral load <50 copies/mL of three or four antiretroviral therapy (ART) regimens among ART naïve patients within the first 16 weeks after the start of treatment. A retrospective study was carried out on ART naïve patients who started HAART between 1 January 1999 and 1 January 2004. ART naïve patients with a viral load >5.3 log
10 copies/mL at the time of treatment were routinely started on four ART regimens in one of the HIV centres in Edinburgh. These patients were compared with ART naïve patients with viral load >5.3 log10 copies/mL at the time of start of three ART regimens in the other centre within the study period. During the study period, of 93 ART naïve patients with a viral load >5.3 log10 copies/mL, 56 and 37 commenced four drug and three drug regimens, respectively. Patients in each group were matched for their age, prevalence of HCV, median age, and median viral load at the start of therapy; however, patients on three drug regimens had significantly lower CD4 counts (P<0.01). The median time to undetectable viral load was 13.5 weeks for three and four drug regimens (P>0.05). By the time of undetectable viral load, there was no difference in the CD4 count of patients on three or four drug regimens. Similar proportions of immunosuppressed patients on three and four ART regimens had undetectable viral load within the first 16 weeks of therapy. [ABSTRACT FROM AUTHOR]- Published
- 2006
- Full Text
- View/download PDF
27. The influence of antiretroviral therapy on the uptake of HIV testing in Tutume, Botswana.
- Author
-
Warwick, Zoe
- Subjects
ANTIRETROVIRAL agents ,ANTIVIRAL agents ,DIAGNOSIS of HIV infections ,COMMUNITIES - Abstract
This paper describes how the national antiretroviral (ARV) programme in Botswana has influenced the willingness of the community of Tutume District, Botswana to come forward for HIV testing. A retrospective review of Tutume Primary Hospital records was performed for three different periods: prior to the national antiretroviral therapy (ART) programme, once ART was available in limited centres and once ART was available locally. There was a five-fold increase in the number of HIV tests performed once treatment became available locally, primarily due to female voluntary testing. Access to free ART increases the HIV testing rate of previously reluctant communities. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
28. Antiretroviral Therapy Management in Adults With HIV During ICU Admission.
- Author
-
Walker, Cheri K., Shaw, Cassie M., Moss Perry, Madeleine V., and Claborn, Melanie K.
- Subjects
INTENSIVE care units ,HIV infections ,OCCUPATIONAL roles ,PATIENTS ,ANTIRETROVIRAL agents ,HOSPITAL admission & discharge ,PHARMACEUTICAL arithmetic ,ADULTS - Abstract
The extended lifespan of people living with human immunodeficiency (HIV) and acquired immune deficiency syndrome (AIDS) (PLWHA) has increased the potential for ICU admissions unrelated to HIV infection. The objective of this review is to guide continued management of antiretroviral therapy (ART) recommended by the United States Department of Health and Human Services Antiretroviral Guidelines in critically ill adult PLWHA admitted to the intensive care unit (ICU). Pharmacists are uniquely positioned to mitigate these concerns, including whether to continue ART in the ICU, drug interactions with common ICU drugs, renal and hepatic dosing considerations, and alternative methods of administration. Despite these concerns, the original ART regimen should be continued or modified in conjunction with an HIV specialist. Discontinuation greater than 2 weeks should be avoided due to potential resistance and future HIV treatment failure. Use of ART in critically ill patients presents challenges that pharmacists are best equipped to address to prevent adverse events, administration errors, and treatment failure. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
29. Relational Risk: How Relationships Shape Personal Assessments of Risk and Mitigation.
- Author
-
Urena, Anthony
- Subjects
HIV infections & psychology ,HIV infection risk factors ,PUBLIC health surveillance ,INTIMACY (Psychology) ,RESEARCH methodology ,HISPANIC Americans ,PSYCHOLOGY of LGBTQ+ people ,HUMAN sexuality ,ANTIRETROVIRAL agents ,INTERVIEWING ,SOCIAL stigma ,RACE ,RISK assessment ,PSYCHOLOGY of gay people ,HARM reduction ,INTERPERSONAL relations ,PSYCHOSOCIAL factors ,DECISION making ,SEXUAL partners ,AFRICAN Americans ,BISEXUAL people ,SOCIAL integration - Abstract
Objects of risk mitigation are typically viewed as neutral items that limit exposure to an established hazard. However, people may refuse to adopt such tools, even when they feel vulnerable. This article explores how people assess their personal risk and mitigation options by examining PrEP use for HIV prevention. Drawing on semi-structured in-depth interviews with 40 Black and Latino gay, bisexual, and queer men, I argue PrEP uptake is a socially contextualized decision influenced by relational concerns. I develop the concept of relational inoculation, wherein individuals enact a sense of protection against harm through relational work. As individuals consider PrEP, they also contemplate how it may bolster or undermine intimacy they value for reducing interpersonal HIV exposure, as well as dispelling stigmatized notions of riskiness held by their intersecting ethno-racial and sexual minority communities. I develop testable propositions about how respondents' HIV risk assessments and PrEP use are enmeshed in a societal context of surveillance, in ongoing relations with intimate partners and socially significant others, and in navigation of community belonging within this milieu of risk. This article contributes to sociological research at the nexus of race, sexuality, and health, and offers health policy insight. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
30. Exploring HIV-Associated Neurocognitive Impairment in the Era of Effective Antiretroviral Therapy: A Primary Healthcare Perspective.
- Author
-
Munsami, Adele, Nightingale, Sam, Sorsdahl, Katherine, and Joska, John A.
- Subjects
HIV infection complications ,COGNITION disorder risk factors ,PROFESSIONS ,FOCUS groups ,ATTITUDES of medical personnel ,RESEARCH methodology ,ANTIRETROVIRAL agents ,MEDICAL screening ,INTERVIEWING ,INTERPROFESSIONAL relations ,HEALTH care teams ,DESCRIPTIVE statistics ,CASE studies ,THEMATIC analysis - Abstract
The prevalence of HIV-associated neurocognitive impairment (H-NCI) is concerning. Individuals on effective antiretroviral therapy (ART) may still be at risk for H-NCI as they experience longer life expectancies. There are, however, few professionals with knowledge and skills to identify H-NCI, in low- and middle-income countries. We explored qualitatively, primary healthcare workers' knowledge and views of H-NCI, in the era of effective ART, particularly their views toward task-sharing of H-NCI screening from specialists to mid-level or lay healthcare providers. The first phase of data collection involved two focus group discussions (FGDs) 23 primary healthcare workers from two facilities in the Western Cape participated in the FGDs. In the second phase of data collection12 individual, in-depth interviews were conducted in KwaZulu-Natal. Using thematic analysis, several key themes emerged. Although healthcare providers were unable to specifically identify H-NCI, they described several HIV disease and treatment related or mental health comorbidities that could be responsible for the symptoms. Despite healthcare workers reporting low frequencies of H-NCI, they favoured receiving training to screen for H-NCI with a view toward providing holistic care. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
31. Rapid Implementation of Evidence-Informed Interventions to Improve HIV Health Outcomes Among Priority Populations: The E2i Initiative.
- Author
-
Marc, Linda G., Goldhammer, Hilary, Mayer, Kenneth H., Cahill, Sean, Massaquoi, Massah, Nortrup, Erin, Cohen, Stacy M., Psihopaidas, Demetrios A., Carney, Jhetari T., and Keuroghlian, Alex S.
- Subjects
HIV infections ,PROFESSIONAL practice ,EVIDENCE-based medicine ,PUBLIC health ,ANTIRETROVIRAL agents ,TREATMENT effectiveness ,HUMAN services programs ,QUALITY assurance ,PATIENT compliance - Abstract
The article describes the application of a novel rapid implementation approach developed by the Health Resources & Services Administration HIV/AIDS Bureau to improve HIV health outcomes among priority populations in the U.S. Topics discussed include evidence-informed intervention strategies, the Ryan White HIV/AIDS Program, and public health implications.
- Published
- 2022
- Full Text
- View/download PDF
32. New injectable antiretroviral therapy for HIV facilitates novel treatment pathways for persons without capacity to consent to medical treatment.
- Author
-
Storrier, Kirbie, Ouliaris, Calina, and George, Duncan
- Subjects
INFORMED consent (Medical law) ,ANTIRETROVIRAL agents ,INVOLUNTARY treatment ,MENTAL health laws ,THERAPEUTICS - Abstract
Objective: The development of new injectable antiretroviral therapy facilitates treatment for Human immunodeficiency virus (HIV) positive individuals who lack capacity to consent, posing a safety risk to both themselves and the wider community. We consider pathways to enforce treatment and propose an algorithm to determine the most appropriate legal instrument for application. Conclusion: Legislative safeguards in mental health and guardianship legislation provide oversight and protection for those who suffer from illness and require coercive treatment. These frameworks have utility in the treatment of HIV patients who lack capacity to consent to treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
33. Optimal Scale‐Up of HIV Treatment Programs in Resource‐Limited Settings Under Supply Uncertainty.
- Author
-
Deo, Sarang, Mehta, Sameer, and Corbett, Charles J.
- Subjects
TREATMENT programs ,HIV ,ANTIRETROVIRAL agents ,DRUG abuse treatment ,PERSPECTIVE taking - Abstract
This study is motivated by the challenges faced by clinics in sub‐Saharan Africa in allocating scarce and unreliable supply of antiretroviral drugs (ARVs) among a large pool of eligible patients. Existing discussion of ARV allocation is focused on qualitative rules for prioritizing certain socioeconomic and demographic patient segments over others at the national level. However, such prioritization rules are of limited utility in providing quantitative guidance on scaling up of treatment programs at individual clinics. In this study, we take the perspective of a clinic administrator whose objective is to maximize the quality‐adjusted survival of the entire patient population in its service area by allocating scarce and unreliable supply of drugs among two activities: initiating treatment for untreated patients and continuing treatment for previously treated patients. The key trade‐off underlying this allocation decision is between the marginal health benefit obtained by initiating an untreated patient on treatment and that obtained by avoiding treatment interruption of a treated patient. This trade‐off has not been explicitly studied in the clinical literature, which focuses either on the incremental value obtained from initiating treatment (over no treatment) or on the value of providing continuous treatment (over interrupted treatment) but not on the difference of the two. We cast the clinic's problem as a stochastic dynamic program and provide a partial characterization of the optimal policy, which consists of dynamic prioritization of patient segments and is characterized by state‐dependent thresholds. We use this structure of the optimal policy to design a simpler Two‐Period heuristic and show that it substantially outperforms the Safety‐Stock heuristic, which is commonly used in practice. In our numerical experiments based on realistic parameter values, the performance of the Two‐Period heuristic is within 4% of the optimal policy whereas that of the Safety‐Stock heuristic can be as much as 20% lower than that of the optimal policy. Our model can serve as a basis for developing a decision support tool for clinics to design their ARV treatment program scale‐up plans. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
34. Using intervention mapping in motivational interviewing training to improve ART uptake in Gauteng, South Africa.
- Author
-
Mokhele, Idah, Sineke, Tembeka, Vujovic, Marnie, Fox, Matthew P, Ruiter, Robert AC, and Onoya, Dorina
- Subjects
HIV prevention ,MOTIVATIONAL interviewing ,CONCEPT mapping ,ANTIRETROVIRAL agents ,MEDICAL care use ,ABILITY ,TRAINING ,PATIENT compliance ,EDUCATIONAL outcomes - Abstract
In South Africa, lay HIV counsellors are at the forefront of many HIV-related behavioural interventions. However, they have limited formal counselling training and little ongoing in-service support, leading to considerable variability in approaches to counselling. We describe the use of Intervention Mapping to develop a motivational interviewing counselling training and support program, titled "Thusa-Thuso - helping you help", for lay HIV counsellors practising in primary health care clinics in South Africa. The program is contextually relevant, locally-produced, scalable, and is designed to impart sustained motivational interviewing counselling skills in lay HIV counsellors for improved antiretroviral therapy (ART) uptake in the universal-test-and-treat era. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
35. Pharmacokinetic Considerations for Selection of HAART in Treatment-Naive HIV-Infected Individuals, 2008: More Than It Seems?
- Author
-
Luber, Andrew D.
- Abstract
The selection of highly active antiretroviral therapy for treatment-naive HIV-infected individuals is complex. In addition to patient adherence, exposures of antiretroviral agents (ARVs) can be influenced by patient population, gender, drug-drug and drug-food interactions, and comorbid medical conditions. In contrast to pharmacokinetic sampling performed under controlled conditions, ARV exposures in "real-world" clinical practice display substantial interpatient variability. The interactions between ARVs and other medications commonly used by HIV-infected patients could significantly impact ARV exposures and need to be considered when selecting therapies. Pharmacogenomic differences have been identified for a number of ARVs, resulting in increased plasma exposures (efavirenz, nelfinavir) or increased risk for adverse drug events (atazanavir, abacavir, indinavir). Despite increasing populations of HIV-infected females and people 50 years or older, the pharmacokinetics of many ARVs has not been adequately studied in these patient populations. The clinical significance of many of these pharmacokinetic differences is unknown. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
36. Health care Providers' Perceptions About Overweight and Obesity Among People Living With Human Immunodeficiency Virus in Nigeria.
- Author
-
Olawepo, John O., Pharr, Jennifer R., Kabir, Raisa, and Olutola, Ayodotun
- Subjects
HIV-positive persons ,OBESITY ,REGULATION of body weight ,HIV infections ,SOCIOLOGY ,ATTITUDE (Psychology) ,RESEARCH methodology ,SOCIAL constructionism ,MATHEMATICAL models ,MEDICAL personnel ,INTERVIEWING ,ANTIRETROVIRAL agents ,QUALITATIVE research ,PHENOMENOLOGY ,THEORY ,THEMATIC analysis ,PATIENT education ,STATISTICAL sampling ,MEDICAL coding ,COMORBIDITY ,OUTPATIENT services in hospitals - Abstract
HIV infection was associated with significant weight loss before the advent of potent antiretroviral therapy (ART). Weight gain while on treatment was seen as a clinical indicator of treatment success. Perceptions of health care providers (HCPs) about obesity among people living with (PLHIV) were examined. We conducted 16 key informant interviews with HCPs in two states in southeastern Nigeria, which were then coded thematically. The respondents included seven physicians, four nurses, three adherence counselors, and two pharmacists. The analysis revealed three key themes: HCPs do not see excess weight gain as a problem; there are several challenges in managing obesity among PLHIV; and comorbidities play a role in the management of obesity among PLHIV. We conclude that obesity among PLHIV is an important clinical issue that HCPs need to address with the commencement of ART. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
37. Adherence to highly active antiretroviral therapy among people living with HIV and associated high-risk behaviours and clinical characteristics: A cross-sectional survey in Vietnam.
- Author
-
Le, Phuong M, Nguyen, Phuong T, Nguyen, Huy V, Bui, Duc H, Vo, Son H, Nguyen, Nga V, Nguyen, Tien V, Tran, Anh TN, Le, Anh DM, Ha, Nguyet MT, Dao, An TM, and Gilmour, Stuart
- Subjects
HIV-positive persons ,ANTIRETROVIRAL agents ,CROSS-sectional method ,MEDICAL care standards ,PATIENT compliance - Abstract
Although Vietnam has promoted the utilisation of highly active antiretroviral therapy (HAART) towards HIV elimination targets, adherence to treatment has remained under-investigated. We aimed to describe high-risk behaviours and clinical characteristics by adherence status and to identify the factors associated with non-adherence. We included 426 people living with HIV (PLWH) currently or previously involved in HAART. Most participants were men (75.4%), young (33.6 years), with low income and low education levels. Non-adherent PLWH (11.5%) were more likely to have a larger number of sex partners (p -value = 0.053), sex without condom use (p -value = 0.007) and not receive result at hospital or voluntary test centre (p -value = 0.001). Multiple logistic regression analysis showed that demographic (education levels), sexual risk behaviours (multiple sex partners and sex without using condom) and clinical characteristics (time and facility at first time received HIV-positive result) were associated with HAART non-adherence. There are differences in associated factors between women (education levels and place of HIV testing) and men (multiple sex partners). Gender-specific programs, changing risky behaviours and reducing harms among PLWH may benefit adherence. We highlight the need to improve the quantity and quality of HIV/AIDS services in Vietnam, especially in pre- and post-test counselling, to achieve better HAART adherence, working towards ending AIDS in 2030. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
38. Ibalizumab: The First Monoclonal Antibody for the Treatment of HIV-1 Infection.
- Author
-
Chahine, Elias B. and Durham, Spencer H.
- Subjects
THERAPEUTIC use of monoclonal antibodies ,ANTIRETROVIRAL agents ,ANTI-HIV agents ,HIV ,AIDS treatment - Abstract
Objective: To review the efficacy and safety of ibalizumab (IBA) in the treatment of HIV-1 infection. Data Sources: A literature search was performed using PubMed and Google Scholar (2010 to mid-June 2020) with the search terms TMB-355, TNX-355, and ibalizumab. Other resources included abstracts presented at recent conferences and the manufacturer's website and prescribing information. Study Selection and Data Extraction: All relevant English-language articles of studies assessing the efficacy and safety of IBA were included. Data Synthesis: IBA is a monoclonal antibody that blocks HIV-1 from infecting CD4+ T cells. IBA is approved by the Food and Drug Administration, in combination with other antiretrovirals (ARVs), for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant (MDR) HIV-1 infection failing their current ARVs. IBA demonstrated significant and sustained antiviral activity in patients with MDR HIV-1 infection who had advanced disease and limited treatment options. It carries a warning regarding the development of immune reconstitution inflammatory syndrome. Common adverse reactions include diarrhea, dizziness, nausea, and rash. Relevance to Patient Care and Clinical Practice: IBA represents an attractive option for treatment-experienced adults with advanced HIV-1 infection who are no longer able to achieve viral suppression on oral ARV therapy alone and who are able to adhere to an infusion therapy every 2 weeks. As with other biologics, there is a potential for the development of antibodies to IBA that can compromise its efficacy and safety. Conclusion: IBA provides a needed treatment option to achieve and maintain viral suppression in heavily treatment-experienced adults with MDR HIV-1 infection. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
39. Virtual HIV pre-exposure prophylaxis outpatient service in the era of COVID-19.
- Author
-
Quirke, Siobhan, Quinn, Laura, Hegarty, Deborah, Loy, Aisling, Lyons, Fiona, Mulcahy, Fiona, and Devitt, Emma
- Subjects
COVID-19 pandemic ,HIV ,OUTPATIENT medical care ,ANTIRETROVIRAL agents ,PREVENTIVE medicine - Abstract
In the midst of the COVID-19 pandemic, health care providers have had to rapidly change how they deliver care to patients. We discuss how we are delivering a virtual HIV pre-exposure prophylaxis (PrEP) service during this time; challenges faced; challenges expected and goals for the coming months. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
40. Leveraging the Photovoice Methodology for Critical Realist Theorizing.
- Author
-
Mukumbang, Ferdinand C. and van Wyk, Brian
- Subjects
PHILOSOPHY of science ,BEHAVIOR therapy ,SOCIAL facts ,EXPONENTIAL functions ,ANTIRETROVIRAL agents - Abstract
Photovoice is a visual research methodology that integrates images and words to encourage the exploration of the experiences, perceptions, and meaning-making processes of individuals on various social phenomena. As a participatory qualitative methodology, Photovoice has been used within the interpretivist paradigm to explore various [public] health and social phenomena to enhance participants' (co-investigators') engagement and to lobby for policy. Despite its exponential growth and extensive application in the last two decades, its potential usefulness in critical realist-informed studies is unexplored. Herein, we highlight the epistemological and methodological alignment of the Photovoice methodology with the critical realist philosophy of science regarding the understanding of social phenomena through meaning-making. Drawing on the authors' work on adolescents' (non)adherence behavior on antiretroviral therapy, we illustrate the application of Photovoice methods in a critical realist-informed qualitative study. The emancipatory potential of the Photovoice methodology aligns with that of critical realist epistemology as they privilege participants' (co-investigators') knowledge generation and learning to better understand and take control of their situation - "integrated" knowledge translation. Methodologically, Photovoice provides a useful dialogue strategy for promoting discussions between the researcher and the co-investigators to obtain value-impregnated accounts to inform critical realist theorizing. The Photovoice methodology is appropriate for theorizing in critical realist research and especially suitable when engaging with suppressed or marginalized populations. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
41. Screening for Traumatic Experiences and Mental Health Distress Among Women in HIV Care in Cape Town, South Africa.
- Author
-
Yemeke, Tatenda T., Sikkema, Kathleen J., Watt, Melissa H., Ciya, Nonceba, Robertson, Corne, and Joska, John A.
- Subjects
HIV prevention ,CHILD sexual abuse ,CONFIDENCE intervals ,MENTAL depression ,PSYCHOLOGICAL distress ,EXPERIENCE ,FISHER exact test ,HIV-positive persons ,MEDICAL screening ,MENTAL illness ,POST-traumatic stress disorder ,QUESTIONNAIRES ,RESEARCH funding ,SEX crimes ,WOMEN'S health ,WOUNDS & injuries ,LOGISTIC regression analysis ,ANTIRETROVIRAL agents ,INTIMATE partner violence ,PATIENTS' attitudes ,DESCRIPTIVE statistics ,ODDS ratio ,MANN Whitney U Test - Abstract
Traumatic events can negatively affect clinical outcomes among HIV positive women, particularly when those events result in ongoing psychological distress. Consequently, there have been calls to integrate screening and treatment of traumatic experiences and associated mental health disorders into HIV care. In South Africa, screening for traumatic experiences and mental health is not a routine part of HIV care. The goal of this study was to examine the prevalence of traumatic experiences and mental health distress among women in an HIV clinic in Cape Town, South Africa, and to explore the acceptability of routine screening in this setting. Seventy HIV positive women were screened following referral from health care workers in the clinic. Among the participants, 51% reported a history of sexual abuse and 75% reported physical intimate partner violence (physical IPV). Among all participants, 36% met screening criteria for depression; among those with traumatic experiences (n = 57), 70% met screening criteria for posttraumatic stress disorder (PTSD). Compared with reporting no sexual abuse or physical IPV, having experienced both sexual abuse and physical IPV was significantly associated with higher odds of depression, while reporting either sexual abuse or physical IPV individually was not significantly associated with increased odds of depression. Among women reporting sexual abuse, 61% were disclosing their experience for the first time during the screening; 31% of women with physical IPV experience were disclosing for the first time. Overall, 98% of participants thought screening should be routine and extended to all women as part of clinic care. Screening women for sexual abuse and physical IPV may be an important component of ensuring HIV care engagement. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
42. Gender differences in enrolment in an HIV-treatment programme in rural Lesotho, 2006-2008: a brief report.
- Author
-
Furin, J., Miller, A. C., Lesia, N., Cancedda, C., Haidar, M., Joseph, K., Ramanagoaela, L., and Rigodon, J.
- Subjects
GENDER differences (Psychology) ,HIV-positive persons ,ANTIRETROVIRAL agents ,THERAPEUTICS ,HIV infections ,RETROSPECTIVE studies - Abstract
The southern African nation of Lesotho has an HIV seroprevalence of approximately 25%. To address the need for HIV care in rural Lesotho, a project called the Rural Health Initative (RHI) was launched in seven clinics in 2006. Data on enrolment were collected retrospectively and analysed for trends in gender enrolment over time. Of 6001 enrolled, 3904 were women (65.1%) and 2097 (34.9%) were men. When analysed by month of enrolment, there was a higher percentage of men enrolled in December compared with the other months of the year (χ
2 = 15.98, P < 0.001). This may be due to the migratory work of the men in the mines of South Africa and suggests a need for targeted interventions to increase male enrolments over the entire calendar year. [ABSTRACT FROM AUTHOR]- Published
- 2012
- Full Text
- View/download PDF
43. Impact of an Antimicrobial Stewardship Team on Reducing Antiretroviral Medication Errors.
- Author
-
Nimarko, Kwabena, Bandali, Aiman, Bias, Tiffany E., and Mindel, Sharon
- Subjects
MEDICATION errors ,ANTIRETROVIRAL agents ,HIV-positive persons ,ANTI-infective agents ,MANN Whitney U Test ,DRUG interactions ,HIV infections ,RETROSPECTIVE studies ,HOSPITAL care ,DISCHARGE planning - Abstract
Background: Numerous interventions have been used to reduce medication errors related to antiretroviral (ARV) therapy for hospitalized patients with HIV. Objective: This study assessed the impact of an antimicrobial stewardship (ASP) team intervention on reducing the rate of ARV therapy errors in patients admitted to an academic medical center. Methods: This observational, retrospective study included patients who received ARV therapy from June 2016 to December 2017. The primary outcome was evaluation of ASP team performance in detecting ARV medication errors in the inpatient setting. Errors were further categorized by type (interaction, dosing, regimen). The Mann-Whitney U test and χ2 tests were utilized to analyze continuous and categorical data, respectively. Results: Medication errors occurred in 51% of patients in the preintervention group (n = 152) and 48% of patients in the postintervention group (n = 203; P = 0.43). The most frequent medication error type was drug interactions in both groups, involving integrase strand transfer inhibitors and polyvalent cations (64% vs 67%). There was a significant difference between preintervention and postintervention groups regarding number of errors detected (13 vs 106, P < 0.001), corrected (12 vs 86, P < 0.001), and persisting at discharge (106 vs 18, P < 0.001). Conclusion and Relevance: Review of ARV regimens by an ASP team significantly decreased medication errors. Drug interactions are the most common medication error found in HIV-positive patients admitted to our academic center. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
44. Middle ear Pathologies in Adults Living with Human Immunodeficiency Virus: A Systematic Review.
- Author
-
Sebothoma, Ben and Khoza-Shangase, Katijah
- Subjects
AUDIOMETRY ,IMPEDANCE audiometry ,CINAHL database ,EAR diseases ,EXPERIMENTAL design ,HIV infections ,PSYCHOLOGY information storage & retrieval systems ,MEDLINE ,MIDDLE ear ,ONLINE information services ,OTITIS media ,SYSTEMATIC reviews ,ANTIRETROVIRAL agents ,CONDUCTIVE hearing loss ,ADULTS - Abstract
Introduction: Middle ear pathologies have been linked with HIV. The onset and development of these pathologies in individuals with HIV have not been categorized; and clarity has not been gained regarding whether their presentation is any different in this population when compared to HIV negative control group. Purpose: The aim of this study was to explore and document published evidence reflecting trends in middle ear pathologies in adults living with HIV. Methods: A systematic review of literature from January 1982 to December 2018 was conducted using Medline, CINAHL, PubMed, and Psych Info. Studies that reported the occurrence rate of middle ear pathologies in adults with HIV and published in English were included. Results: Twelve articles met the inclusion criteria. Evidence suggests that the reported occurrence rates of middle ear pathologies ranges from 2.5% to 58% in this population. The variability in assessment measures as well as the different cut-off criteria used in studies seem to have an influence in the findings, with pure tone audiometry identifying more middle ear pathologies in the current review than tympanometry with 226 Hz probe tone and clinical examination. Otitis media, conductive hearing loss, and type B tympanogram were common findings reported in this study. No evidence of an association between the use of antiretroviral therapy (ART) and the rates of middle ear pathologies was found. Conclusion: Although there are very few studies that have reported on middle ear pathologies in adults living with HIV, the available studies have sufficiently established a link between HIV and middle ear disease in this population, and have revealed that the rate of occurrence is influenced by a number of factors. Key amongst these is the type of assessment measure used. Careful analysis of middle ear pathologies in this population through well controlled research designs that include different assessment measures. The use of case-control and longitudinal designs to determine differences between groups and to establish the time of onset and development of middle ear pathologies is required. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
45. Viral load outcomes in a cohort of alcohol-consuming people living with HIV receiving antiretroviral therapy in Mumbai, India.
- Author
-
Sarna, Avina, Singh, Roopal J, Schensul, Jean J, Gaikwad, Sushma S, Joshi, Kavita, Malye, Rupal, Mahapatra, Bidhubhushan, Ha, Toan, and Schensul, Stephen
- Subjects
VIRAL load ,HIV ,ALCOHOL drinking ,ANTIRETROVIRAL agents ,VIROLOGY - Abstract
We examined the association between alcohol consumption, adherence and viral load (VL) in a cohort of 940 alcohol-consuming, human immunodeficiency virus (HIV)-positive men receiving antiretroviral therapy in Mumbai. Some of the participants (16.7%) had missed >1 doses in the last four days and 17.6% reported >1 treatment interruptions in the last 12 months; 60.8% of the participants consumed alcohol >2 times/month, 62.8% consumed >3 drinks/typical day and 11.5% reported binge drinking >1 times/month; 76.4% of the participants had VL<200 copies/mL. Higher alcohol consumption was associated with nonadherence (odds ratio [OR]: 1.21; 95% confidence interval [CI]: 1.11-1.31) and treatment interruptions (OR: 1.20; 95% CI: 1.11-1.31). We found no association between alcohol use and VL. There was, however, a significant interaction effect of alcohol use and nonadherence on virological failure (Adjusted Odds Ratio [AOR]: 1.23; 95% CI: 1.03-1.47) implying that alcohol negatively impacts VL outcomes but mediated through adherence. Alcohol use was associated with poor adherence, which in turn was a strong predictor of virological failure. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
46. Effectiveness, Safety, and Costs of Dolutegravir/Abacavir/Lamivudine Single-Tablet Regimen in a Real-Life Cohort of HIV-1 Adult Infected Patients.
- Author
-
Rodriguez-Gonzalez, Carmen Guadalupe, Chamorro-de-Vega, Esther, Ortega-Navarro, Cristina, Alonso, Roberto, Herranz-Alonso, Ana, and Sanjurjo-Saez, Maria
- Subjects
ADVERSE health care events ,MEDICATION safety ,ANTIRETROVIRAL agents ,COST effectiveness ,HIV-positive persons ,ANTI-HIV agents ,HIV infections ,DRUG tablets ,COMBINATION drug therapy ,HETEROCYCLIC compounds ,DEOXYRIBONUCLEOSIDES ,RETROSPECTIVE studies ,LAMIVUDINE ,TREATMENT effectiveness ,HIV ,LONGITUDINAL method ,PROPORTIONAL hazards models - Abstract
Background: Real-life data on single-tablet regimen (STR) dolutegravir/abacavir/lamivudine (DTG/ABC/3TC) is scarce, and concerns about DTG neuropsychiatric adverse events (NP-AEs) have recently arisen. Objective: To explore the effectiveness and safety, in particular NP-AEs, of DTG/ABC/3TC in a cohort of HIV-1 adult infected patients. Pill burden, adherence to this STR, and the impact of switching on costs were also evaluated. Methods: This was an observational, retrospective study. The study population included antiretroviral therapy (ART)-naive and treatment-experienced (TE) patients who started DTG/ABC/3TC between February 1, 2016, and October 31, 2016. Effectiveness and safety were analyzed at week 48 (W48) by intention-to-treat analysis. The Cox regression model was used to investigate predictors of DTG/ABC/3TC discontinuation. Results: A total of 253 patients were included (44 ART naïve, 209 TE). At W48, the proportion of patients with virological suppression was 72.7% (95% CI = 58.4-87.0) in ART-naive patients, 85.6% (95% CI = 80.3-90.9) in previously suppressed TE patients, and 86.4% (95% CI = 65.1-97.1) in previously not suppressed TE patients. The rate of protocol-defined virological failure was 4.3%. The incidence of AEs was higher in the subgroup of ART-naive patients (56.1% vs 39.0%), with a rate of interruptions for this reason of 13.6% and 7.6%, respectively. The incidence of NP-AEs was 20.6%, with 3.9% of patients requiring discontinuation. Patients who had switched from a raltegravir-containing regimen discontinued DTG/ABC/3TC because of AEs more frequently (relative risk = 2.83; 95% CI = 1.04-7.72; P = 0.041) in the multivariate analysis. After switching to DTG/ABC/3TC, the median pill burden was reduced from 3 to 1 and the proportion of patients with an adherence <90%, from 20.1% to 12.0%. The annual per-patient ART costs increased by €48 (0.6% increase). Conclusion and Relevance: DTG/ABC/3TC is an effective strategy as first-line and switching ART. Our data suggest a worse tolerance in ART-naive patients, although the rate of discontinuation resulting from NP-AEs was relatively low. In the short-term, the adherence was slightly improved without significant changes in costs. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
47. Prevalence of renal dysfunction and associated risk factors among HIV patients on ART at the Bamenda Regional Hospital, Cameroon.
- Author
-
Che Awah Nforbugwe, Achu, Acha Asongalem, Emmanuel, Bihnwi Nchotu, Rengerline, Asangbeng Tanue, Elvis, Sevidzem Wirsiy, Frankline, and Nguedia Assob, Jules Clement
- Subjects
HIV-positive persons ,PATIENT compliance ,CD4 lymphocyte count ,GLOMERULAR filtration rate ,ANTIRETROVIRAL agents - Abstract
Since the advent of the management of HIV/AIDS using combination antiretroviral therapy (ART), the leading causes of morbidity and mortality in people living with HIV (PLWH) have changed from infectious to non-infectious causes with kidney disease increasingly emerging as being significant. Despite the introduction of the 'test and treat' strategy in Cameroon, there are still few data available on the effect of ART on renal function. Thus, this study aimed to determine the prevalence of renal dysfunction among PLWH on ART and its associated risk factors. We conducted a hospital-based comparative cross-sectional study involving PLWH naïve to ART and those on ART. Spectrophotometry was used to quantify renal markers. Glomerular filtration rate was estimated by the creatinine clearance (CrCl) method. Participants with CrCl <60 ml/min/1.73 m
2 were considered to have renal dysfunction. A total of 136 participants were recruited of which 97 (71.3%) were females. The mean age was 39.5 ± 9.2 years. Each study category had the same number of participants (68 each). Both had a prevalence of proteinuria of 50%. Of the total study population, 26 (19.1%) had CrCl <60 ml/min/1.73 m2 . About 82.4% of the participants on ART were on tenofovir-based regimens with a mean duration of treatment of 6.95 ± 3.74 years. The ART-experienced group had a prevalence of renal dysfunction of 26.5% and the ART-naïve group 11.8%. The difference in mean CrCl between the study groups was not statistically significant. There was no association between renal dysfunction and the ART regimen, duration on treatment, or adherence to treatment. Our study demonstrated a high prevalence of renal dysfunction among PLWH that was associated with increasing age. Decreased CD4 cell count increased the risk of proteinuria. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
48. Delays in HIV and TB diagnosis and treatment initiation in co-infected patients in Colombia.
- Author
-
Ríos-Hincapié, Cielo Yaneth, Rojas, Marcela, López, Martha, Porras, Alexandra, Luque, Ricardo, Pelissari, Daniele Maria, López, Lucelly, and Rueda, Zulma Vanessa
- Subjects
IMMUNE reconstitution inflammatory syndrome ,CD4 lymphocyte count ,HIV ,TUBERCULIN test ,TUBERCULOSIS patients ,ANTIRETROVIRAL agents - Abstract
We investigated the delays in the diagnosis of tuberculosis and/or HIV, their treatment initiation, and factors associated with each delay. All drug-susceptible tuberculosis cases diagnosed in 2014 and 2015 in Colombia, with a confirmed diagnosis of HIV were included. A total of 1909 patients were registered with tuberculosis/HIV co-infection. Seventy-nine percent of patients were men, 50% had sputum smear-negative tuberculosis, culture was done in 50% of cases, 68.5% had <200 CD4 cell count at diagnosis, and 35% had concurrent tuberculosis/HIV diagnosis. Delays in the tuberculosis diagnosis were identified in 54.8% of the patients, and delays in tuberculosis and HIV treatment initiation in 41.8% and 27.4%, respectively. The risk factors associated with delay in tuberculosis diagnosis were age between 15–34 and ≥45 years, and those patients who received tuberculin skin test. The risk factor associated with antiretroviral therapy initiation delay was previously-treated tuberculosis patients after failure. It is necessary to implement strategies for early detection and treatment initiation of HIV and to use rapid test for tuberculosis diagnosis in this population. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
49. Doravirine: A Return of the NNRTI Class?
- Author
-
Blevins, Sarah R., Hester, E. Kelly, Chastain, Daniel B., and Cluck, David B.
- Subjects
DRUG interactions ,ANTIRETROVIRAL agents ,CLINICAL drug trials ,TREATMENT effectiveness ,DATA extraction - Abstract
Objective: To compare and contrast doravirine (DOR) with other agents in the nonnucleoside reverse transcriptase inhibitor (NNRTI) class, review safety and efficacy data from both completed and ongoing clinical trials, and outline the potential place in therapy of DOR. Data Sources: A literature search using the PubMed database (inception to June 2019) was conducted using the search terms HIV, doravirine, non-nucleoside reverse transcriptase inhibitor, NNRTI, and MK-1439. Study Selection and Data Extraction: Clinical data were limited to those published in the English language from phase 2 or 3 clinical trials. Ongoing trials were identified through ClinicalTrials.gov. Data Synthesis: DOR was approved by the US Food and Drug Administration on the strength of 2 phase 3 randomized, double-blind, noninferiority clinical trials with additional studies currently underway examining its utility in other clinical scenarios. Relevance to Patient Care and Clinical Practice: The role of NNRTIs as part of antiretroviral (ARV) therapy has diminished in recent years given the introduction of more tolerable individual ARV agents and regimens. Despite this, new agents are still needed in the therapeutic arena because treatment failure as well as intolerance can still occur with many first-line therapies. The optimal place in therapy of DOR remains to be defined. Conclusions: DOR is a new NNRTI that represents a potential treatment option for treatment-naïve patients, without many of the previously described untoward effects of the NNRTI class. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
50. Incidence and significance of elevated platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios among hospitalised HIV-positive adult patients.
- Author
-
Merriman, Rebekah C, Dissanayake, Oshani, Alnjar, Sara, Burns, Fiona, and Miller, Robert F
- Subjects
FISHER exact test ,C-reactive protein ,VIRAL load ,ANTIRETROVIRAL agents - Abstract
There is increasing interest in the peripheral blood platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) as markers of systemic inflammation. We audited records of unselected hospitalised HIV-positive adults to identify the frequency of elevated PLR and NLR, potential associations with specific diagnoses, and outcome. Of 259 patients audited, their median age was 47 years (interquartile range = 41–54); 188 (73%) were men. An elevated PLR occurred in 87 patients (33.6%); 67 (25.9%) had an elevated NLR; 200 (77%) had an elevated C-reactive protein (CRP). Elevated PLR and NLR was associated with a variety of infectious, inflammatory, and malignant conditions similar to conditions described in the general non-HIV-infected adult population. Additionally, elevated PLR and NLR occurred both in patients in receipt of antiretroviral therapy (with undetectable viral loads), as well as in those with newly-diagnosed and poorly-controlled infection. Fourteen patients with infectious and inflammatory conditions had an elevated PLR and normal CRP, with/without elevated NLR. There was no association between elevated PLR or NLR and ICU admission, p = 0.1001 and p = 0.605, respectively. Elevated NLR, but not PLR was associated with death, p = 0.0405 and p = 1.000, respectively: two-tailed Fisher's exact test. The single site nature of the audit and relatively small number of patients limits these observations. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.